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OBSTACLES TO OBTAINING AND ENFORCING
INTELLECTUAL PROPERTY RIGHTS IN THE
MARIJUANA INDUSTRY
Emily Pyclik'
ABSTRACT
While many individual states have legalized the use of marijuana, it remains
federally illegal. These contrary laws present unique issues for businesses, courts,
and attorneys. This note overviews the obstacles a marijuana business owner may
face when trying to secure intellectual property rights. Next, this note addresses
the difficulties posed in enforcing marijuana-related intellectual property.
Because marijuana patents have yet to be asserted in courts, this note looks at
holdings from other areas of law involving marijuana cases. While it is unclear
what action courts will take when faced with a marijuana-relatedpatent case, this
note concludes by identifying trends in the federal courts and overviews other
potential issues a marijuana-relatedintellectualproperty owner should consider
before litigating.
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INTRODUCTION
A dichotomy exists between how federal and state laws treat marijuana.
Federally,

marijuana

remains illegal.

In 2016,

the Department

of Justice

reaffirmed its position to treat marijuana as a Schedule 1 controlled substance
under the Controlled Substances Act of 1970 (CSA), alongside heroin and LSD. 2
By giving marijuana a Schedule 1 label, the government concluded that marijuana
has a high potential for abuse, has no currently accepted use for medical treatment
in the US, and lacks acceptable safety use under medical supervision. 3 However,
eight states have legalized marijuana for both medical and recreational uses:
Alaska,

California,

Washington.'

Colorado,

Maine,

Massachusetts,

Nevada,

Oregon,

and

Twenty-nine states currently allow marijuana for medical uses. 5

Although states have passed laws in this area that are contrary to federal law, the
Supreme Court revealed how this issue of contrary laws would be resolved in
United States v. OaklandCannabisBuyers' Cooperative.6 The Court held that the

CSA's prohibition on manufacturing and distributing marijuana provides no
medical necessity exception, even for medical reasons recognized by states. 7
Because of the Supremacy Clause of the Constitution, the CSA will trump state
laws that recognize medical uses for marijuana.' The Court emphasized that it is

Congress' role, not the role of the Court, to define federal crimes. 9 In this role,
Congress defined marijuana use as a federal crime and determined that it has "no
currently accepted medical use."o10
Despite the continued

federal illegality,

the market for marijuana has

significantly grown in recent years. In part, this was due to the Obama

administration's choice not to enforce the CSA for marijuana in states that had
legalized it." The administration released a series of memoranda in 2013 and

2 Denial

of Petition To Initiate Proceedings To Reschedule Marijuana, 81 Fed. Reg. 53,767,
53,767 (Aug. 12, 2016).
' 21 U.S.C. § 812(b)(1) (2012).
4 State Medical Marijuana Laws, National Conference of State Legislators, (Dec. 29, 2017),
http://www.ncsl.org/research/health/state-medical-marijuana-laws.aspx (providing a full list of
states that have legalized marijuana for various purposes).
5 Id.
6 United
7 Id.

8

States v. Oakland Cannabis Buyers' Cooperative, 532 U.S. 483, 483 (2001).
at 494.

Id.

9 Id. at 490.

'o Id. at 491.
" See Memorandum from James M. Cole, Deputy Att'y Gen., U.S. Dep't of Justice, (Aug. 29,
2013), http://www.justice.gov/iso/opa/resources/3052013829132756857467.pdf (writing to all
U.S. Attorneys); see also Memorandum from Monty Wilkinson, Dir., Exec. Office for U.S.
Attorneys, U.S. Dep't of Justice, (Oct. 28, 2014),
http://www.justice.gov/sites/default/files/tribal/pages/attachments/2014/12/1 1/policystatementrega
rdingmarijuanaissuesinindiancountry2.pdf.
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2014 (the Cole Memos) where the government revealed it would take a hands-off
approach to marijuana regulation and directed the US Attorneys to take a
deferential

approach

toward

state

marijuana

laws. 12 However,

the Trump

administration has indicated that it may not continue the deferential treatment
under the Cole Memos, leaving those in the marijuana industry unclear about
what stance

businesses.

the government will take and how

it may affect marijuana

13

Congress has also taken action to temporarily protect states in conflict with
federal law and aimed specifically at medical marijuana. Congress passed a
temporary rider that prohibits the Department of Justice and Drug Enforcement
Administration from using funds to prevent states from implementing their
medical marijuana laws. 14 It reads as follows:
None of the funds made available in this Act to the Department of Justice
may be used, with respect to any of the States of Alabama, Alaska,
Arizona, California, Colorado, Connecticut, Delaware, Florida, Georgia,
Hawaii, Illinois, Iowa, Kentucky, Louisiana, Maine, Maryland,
Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana,
Nevada, New Hampshire, New Jersey, New Mexico, New York, North
Carolina, Oklahoma, Oregon, Rhode Island, South Carolina, Tennessee,
Texas, Utah, Vermont, Virginia, Washington, and Wisconsin, or with
respect to either the District of Columbia or Guam, to prevent any of them
from implementing their own laws that authorize the use, distribution,
possession, or cultivation of medical marijuana. 15
In August of 2016, the Ninth Circuit in United States v. McIntosh consolidated
five cases charging the defendants
defendants

with federal marijuana offenses.

16

The

asked the court to dismiss their indictments or to enjoin their

prosecutions,

arguing

that § 542

of the Consolidated

Appropriations Act

prevented the DOJ from spending the funds to prosecute them. 1

The Ninth

Circuit agreed and concluded "at a minimum, § 542 prohibits DOJ from spending
funds from relevant appropriations acts for the prosecution of individuals who
engaged in conduct permitted by the State Medical Marijuana Laws and who fully
complied with such laws."

12

In other words, the rider prohibits federal prosecutors

Memorandum from James M. Cole, Deputy Att'y Gen.

13 Reid Wilson, Confusion mounts over Trump administration'sstance on marijuana,THE HILL
(Feb. 28, 2017), http://thehill.com/homenews/state-watch/321639-confusion-mounts-over-trumpadministrations-stance-on-marijuana.
14 Consolidated Appropriations Act of 2016, Pub. L. No. 114-113, § 542, 129 Stat. 2242, 2332-33
(2015).

15 Id.
16 United
17

States v. McIntosh, 833 F.3d 1163, 1164 (9th Cir. 2016).

Id.

" Id. at 1177.
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from going after patients and providers who are operating in accordance with
local laws. The court emphasized that the protections only provide temporary
relief,

so long as Congress continues to include similar riders in future

appropriation bills. 19
Despite attempts to ease the burdens on marijuana businesses by the former
administration and Congress, federal and state laws still conflict. As a result,
marijuana businesses face some unique hurdles. These include limits in the
business's ability to: deduct business expenses for tax purposes, use banking
services, enforce contracts, and obtain bankruptcy protection.

20

While marijuana

businesses are subject to several of the federal law's burdens, they are unable to
take advantage of federal benefits due to the nature of their businesses. Further,
marijuana businesses may face difficulties in obtaining and enforcing intellectual
property.
Part I of this note outlines the road to the USPTO issuing patents for
marijuana. For now, the USPTO is granting patent protection for novel marijuana
strains.
Part II provides an overview of why the USPTO denies trademarks for
marijuana-related goods. Notably, the USPTO denies trademark protection for
marijuana marks because of the inability to legally use the mark in commerce.
This note points out a possible loophole that international marijuana businesses
may utilize to obtain priority for a marijuana mark in the United States.
Part III identifies the obstacles marijuana-related IP owners face if seeking a
remedy in court. These obstacles include: parties raising equitable defenses like
unclean hands at trial, problems trying to get an attorney to work on a case
involving a marijuana business, and problems with discovery if a party attempts
to invoke the Fifth Amendment. Further, marijuana has been a secret business for
so many years that a party seeking to find prior art to invalidate a patent may face
a serious burden.

With trademarks, a court could cancel a trademark if it

determines that an owner is using the mark with illegal goods. Finally, because
marijuana is still considered illegal or immoral by many people, the parties may
encounter a biased jury.
Part IV explores other areas of law in which courts have ruled on rights for
issues involving marijuana, and how this treatment may similarly affect marijuana
IP owners.
This note concludes by identifying trends of how courts are dealing with
marijuana litigation in other areas of law. A marijuana IP owner would be wise to
consider these trends when deciding where to file suit and what type of remedy to

Id. at 1179
Sam Kamin & Viva Moffat, TrademarkLaundering, Useless Patents, and Other IP Challenges
for the MarijuanaIndustry, 73 Wash. & Lee L. Rev. 217, 217-84 (2016).
19
20
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seek from the courts. Further, when entering into license agreements, a choice of
law or venue clause may be crucial. Alternatively, an arbitration agreement may
be desirable to help keep the IP out of federal courts. Each part will provide these
and other possible solutions, along with identifying associated problems.

I. OBTAINING PATENT PROTECTION FOR MARIJUANA
The government has granted at least four-dozen
patents.

21

cannabis-related utility

Interestingly, even the U.S. government holds a patent for using non-

psychoactive cannabinoids to protect the brain from damage or degeneration
caused by certain diseases, such as cirrhosis. 22 Some argue this is hypocritical
because the government holds a utility patent for a medical use for marijuana, yet
continues to identify it as a Schedule I controlled substance with no legitimate
medical use. 23 The U.S. Government developed the invention inside the National
Institutes of Health (NIH), an agency of the United States Department of Health
& Human Services. The NIH conducts and funds research involving marijuana,
and filed this patent on behalf of the U.S. Government. The patent states

"Cannabinoids have been found to have antioxidant properties... This new found
property makes cannabinoids useful in the treatment and prophylaxis of a wide
variety of oxidation associated diseases... Nonpsychoactive cannabinoids, such as
cannabidoil, are particularly advantageous to use because they avoid toxicity that

is encountered with psychoactive cannabinoids ... "24 The U.S. Government has
even licensed this patent to Kannalife, a biopharmaceutical
develops

cannabinoid-based

therapeutics.

25

Further,

the

company that

Food

and

Drug

Administration, also part of the federal government, has approved the drugs
Marinol and Syndros. 26 These drugs are synthetic forms of THC, the primary
psychoactive cannabinoid in marijuana. However, the FDA has not yet approved
any product containing or derived from botanical marijuana.
While still not approved by the FDA, the United States Patent and Trademark
Office (USPTO) has begun granting utility patents for marijuana that contain
significant amounts of the active ingredient THC.27 U.S. Patent 9,095,554 issued

Alicia Wallace, Patent No. 6,630,507: Why the U.S. government holds a patent on cannabis
plant compounds, THE DENVER POST (Updated Oct. 2, 2016, 4:37 PM),
21

http://www.denverpost.com/2016/08/28/what-is-marijuana-patent-6630507/.
22 U.S. Patent No. 6,630,507 (filed Apr. 21,
1999).
23

See Wallace, supra note 21.

24

See '507 Patent.

25
26

See Wallace, supra note 21.
FDA and Marijuana:Questions andAnswers (Feb. 28, 2017),

https://www.fda.gov/newsevents/publichealthfocus/ucm421168.htm#notapproved.
27 U.S. Patent No. 9,095,554 (filed Mar. 17, 2014) (issued Aug.
4, 2015).
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on August 4, 2015 covers: the plant itself, a method of breeding the plant, and
edible cannabis products containing the patented invention. The patent states:
"There is a real need for cannabis varieties for potential medical use that
produce modulated THC concentrations and varying concentrations of
other pharmacologically active substances. There is also a need for
healthier cannabis for recreational use with reduced negative side effects
from THC. The inventions described herein meet that long-felt need.' 28
The USPTO is now issuing patents for both medical and recreational marijuana
containing the psychoactive ingredient THC.2 9
While the USPTO had a history of rejecting patents for being immoral, in
1977 the Board of Patent Appeals and Interferences ruled in Ex Parte Murphy that
a utility rejection for morality reasons was inappropriate."o In Ex Parte Murphy,
the Patent Board stated:

"[W]e cannot find any basis in 35 U.S.C. 101 or related sections which
justify a conclusion that inventions which are useful only for gambling
ipso facto are void of patentable utility. . . [W]e think this office should
not be the agency which seeks to enforce a standard of morality with
respect to gambling, by refusing, on the ground of lack of patentable
utility, to grant a patent on a game of chance if the requirements of the

Patent Act otherwise have been met."
The Board reversed the rejection for lack of patentable utility.

In 1999, the Federal Circuit clearly put an end to "the principle that inventions
are invalid if they are principally designed to serve immoral or illegal purposes"
because neither the USPTO nor the courts should serve as arbiters of morality. 1
In Juicy Whip, Inc. v. Orange Bang, Inc., the court held that:
"Congress never intended that the patent laws should displace the
police powers of the States, meaning by that term those powers by which
the health, good order, peace and general welfare of the community are

promoted ... we find no basis in section 101 to hold that inventions can be
ruled unpatentable for lack of utility simply because they have the

capacity to fool some members of the public."

32

Therefore, so long as the invention is "capable of providing some identifiable
benefit," it meets the statutory requirement for use.
The USPTO's patent division issues patents that comply with applicable
statutes, and there are no special statutory requirements or restrictions placed on
patenting marijuana plants. The USPTO now includes in the Manual of Patent
28

29
30
31
32

d
Id.

Ex parte Murphy, Sagan, Rosenthal, and Ostrowski, 200 U.S.P.Q. 801 (B.P.A.I. 1977).
Juicy Whip, Inc. v. Orange Bang, Inc., 185 F.3d 1364, 1366 (Fed. Cir. 1999).
Id. at 1368 (citing Webber v. Virginia, 103 U.S. 344, 347-48 (1880).
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Examining Procedure that "[a] rejection under 35 U.S.C. 101 for lack of utility
should not be based on grounds that the invention is frivolous, fraudulent or

against public policy." 33 So, the fact that marijuana is federally illegal, and may
be considered immoral by some, has not stopped the USPTO from issuing patents
on it.
II. OBTAINING TRADEMARK PROTECTION FOR MARIJUANA
While the USPTO has begun issuing patents covering marijuana inventions, it
is still rejecting marijuana-related trademarks. To be eligible for federal trademark
protection, the law requires the use of the trademark in U.S. commerce. 34 Because
marijuana is federally illegal, the USPTO is rejecting marijuana marks for failure
to meet the use in commerce requirement.
The Trademark Trial and Appeal Board (TTAB) has affirmed rejections by
trademark examiners for marijuana-related products due to an inability to legally
use the products in commerce.3 5 In In re Brown, the Board affirmed a trademark

examiner's refusal to register "Herbal Access" for "retail store services featuring
herbs" after finding that the applicant engaged in marijuana sales.36 The TTAB
held that the trademark's use in commerce would be unlawful under federal law,

and, thus, the PTO denied the applicant's registration. To qualify for a trademark
or service mark, the use in commerce must be lawful.

In In re JJ206, the case arose from an examiner's refusal to register the marks
"Powered by Juju" and "Juju Joints" for smokeless cannabis-vaporizing devices
because the applicant could not establish an intent to use the marks in lawful
commerce.3 ' Because the federal Controlled Substances Act outlaws the sale of
marijuana paraphernalia, registration was not permitted because actual lawful use
in commerce was not possible. In other words, it is a legal impossibility to have a
bona fide intent to use a mark for illegal goods in commerce. 3 Therefore, because
there is no lawful use, illegal goods cannot serve as a basis for federal registration.
The USPTO includes in its Trademark Manual of Examining Procedures that

"[u]se of a mark in commerce must be lawful use to be the basis for federal
registration of the mark." 39 The manual specifically mentions the following about
marijuana and its use in commerce:

Manual of Patent Examining Procedure § 706.03(a).
15 U.S.C. § 1051.
35 See In re Brown, 119 U.S.P.Q.2d 1350 (T.T.A.B. 2016); see also In re JJ206, LLC, No.
86474701 (T.T.A.B. 2016).
36 In re Brown, 119 U.S.P.Q.2d 1350 (T.T.A.B. 2016).
37 In re JJ206, LLC, No. 86474701 (T.T.A.B. 2016).
33

34

38 See id.
'9 See Trademark

Manual of Examining Procedure § 907 (April 2016).
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[E]vidence indicating that the identified goods or services involve the sale
or transportation of a controlled substance or drug paraphernalia in
violation of the Controlled Substances Act ("CSA") . . . would be a basis
for issuing an inquiry or refusal . . . Subject to certain limited statutory
exceptions, the CSA makes it unlawful to manufacture, distribute, or
dispense a controlled substance; possess a Schedule I controlled
substance; or sell, offer for sale, or use any facility of interstate commerce
to transport drug paraphernalia . . . Note that, regardless of state law,
marijuana and its psychoactive component, THC, remain Schedule I
controlled substances under federal law and are subject to the CSA's
prohibitions.40
So, until the federal government legalizes marijuana, the USPTO will likely
continue rejecting marijuana-related trademark applications.
If a trademark owner admits that their mark is associated with illegal goods in
commerce, this is perilous because a trademark owner will risk federal criminal
prosecution by admitting this on the record. However, ancillary businesses can get
trademark protection for legal goods and services related to marijuana, like
merchandise that says marijuana or otherwise contains a protectable marijuanarelated mark.4 1 In fact, the USPTO has allowed several marks that use the word

"marijuana" or images of marijuana plants, including the mark "KITTYJUANA"
for catnip, "NO ONE BELONGS IN JAIL FOR MARIJUANA!," and
"MARIJUANA INTERNATIONAL," for a cannabis advertising services
company.4 2
There

are examples

of ancillary

businesses

beating

actual

marijuana

businesses to the USPTO for their marks. Rohan Marley, son of legendary Reggae
musician Bob Marley, announced the start of a global cannabis brand, Marley
Natural, in 2014.43 But soon afterward, a tobacco exporter, with no connection to

Marley, filed trademarks for "Natural Marley Spirit Marijuana" which contained a
lion and cannabis leaf. Yet, because the Marley Natural brand is associated with
marijuana, their mark would not be eligible for trademark protection. 44 If the U.S.
ever federally legalizes marijuana, ancillary businesses that use marijuana in their
marks, like tobacco exporters, will have a head start in incorporating marijuana

See id.
See Sam Kamin & Viva Moffat, TrademarkLaundering, Useless Patents, and Other IP
Challengesfor the MarijuanaIndustry, 73 Wash. & Lee L. Rev. 217, 217-84 (2016).
42
40
41

See, e.g., KITTYJUANA, Registration No. 4445944; NO ONE BELONGS IN JAIL FOR

MARIJUANA!, Registration No. 4372165; MARIJUANA INTERNATIONAL, Registration No.
4110524.
43 See Jason Blevins, Pot growers cultivating in the shadows seek U.S. patent protection, THE
DENVER POST (Apr. 26, 2016), http://www.denverpost.com/2014/12/19/pot-growers-cultivatingin-the-shadows-seek-u-s -patent-protection/.
44 Id.

Vol. 9:1
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into their existing businesses and with an established goodwill. This could give
these ancillary businesses an advantage in being able to select marks first.
Another option that marijuana businesses previously used to seek protection
for their business names was pursuing protection for the use of their marks on
different merchandise, like hats, t-shirts, coffee mugs, etc., in lieu of protection
relating to the use of the marijuana product itself.

Entities used this method as

"trademark laundering", which initially starts with a trademark application for
legal goods.4 5 The entity would get the mark approved for its legal goods, but then
expand the goods or services attached to the mark by using it on additional goods
and services not mentioned in the application. For example, a marijuana business
may apply for a mark for their legal merchandise, but then, after obtaining
registration, also use it on marijuana or marijuana paraphernalia.
However, the PTO may reject or cancel a mark due to trademark laundering
involving illegal goods or services. The Trademark Trial and Appeals Board of
the USPTO delivered a blow to marijuana businesses with its 2016 In re Morgan
Brown decision.4 6 The Board affirmed the refusal to register the mark HERBAL

ACCESS for "retail store services featuring herbs." 4 7 To qualify for federal
registration, a mark must be in lawful use. Therefore, any goods or services an
applicant attaches to the mark must not be illegal under federal law. 48 The
Trademark Office is not precluded from using external evidence, like the
applicant's website, to conclude that the identified goods or services encompass
cannabis.
While marijuana businesses may not be eligible for federal

trademark

protection, they may be eligible for state trademark protection. This state-level
protection is unique to trademarks because states are unable to provide patent-like
protection. 49 Businesses are clearly taking advantage of state protection. For
example, as of July 2015, there were over 200 marijuana trademark registrations
in Colorado.50 However, state trademarks have important limitations: they are

only enforceable within a state's borders, and they require navigating multiple
state laws to receive protection if sought in multiple states. 5 1
Another strategy an entity could use to obtain trademark protection in the
United States would be to first secure protection in another country where
See Kamin, supra note 41.
In re Morgan Brown, 119 USPQ2d 1350 (T.T.A.B. 2016) [precedential].
47 Id.
45
46

48 Id.

49 See Sears, Roebuck & Co. v. Stiffel Co., 376 U.S. 225, 231 (1964). See also Bonito Boats, Inc.

v. Thunder Craft Boats, Inc., 489 U.S. 141 (1989).
5o See Sam Kamin & Viva Moffat, TrademarkLaundering, Useless Patents, and Other IP
Challengesfor the MarijuanaIndustry, 73 Wash. & Lee L. Rev. 217, 217-84 (2016).
51 See Sam Kamin & Viva Moffat, TrademarkLaundering, Useless Patents, and Other IP
Challengesfor the MarijuanaIndustry, 73 Wash. & Lee L. Rev. 217, 217-84 (2016).

2017

AM. U. INTELL. PROP. BRIEF

36

marijuana is legal. Some other countries have legalized marijuana for medicinal
or recreational use, including some members of the TRIPS Agreement.5

2

Since

the United States is a member of the TRIPS agreement, it is required to adhere to
the minimum standards set forth in the agreement. One such requirement is that
the nature of the goods cannot form an obstacle for trademark protection. 3

So, if

someone were to obtain trademark protection for marijuana in a TRIPS country,
then the United States could not deny protection for it on the basis of its nature.
There are exceptions to the agreement, including that a nation can opt to not

enforce sections if "necessary to protect public morals." 5 4 However, the USPTO
has denied trademark protection for lack of use in commerce due to its illegality,
not due to immorality.5 5
To avoid a denial for use by the USPTO, an entity could first file abroad in a
TRIPS member country where marijuana is legal. After obtaining trademark
protection abroad they could then apply for U.S. trademark protection. Under

TRIPS, "actual use of a trademark shall not be a condition for filing an
application for registration."

56

Therefore, applications based on prior foreign

applications from a different country of origin are entitled to U.S. registration
without any actual use. In SCM Corp. v. Langis Foods Ltd., the Court of Appeals
for the District of Columbia held that a corporate foreign national, who applied
for trademark registration in its home country, had priority in registering that
mark over a domestic corporation, even though it had yet to use the mark in the
U.S. 57 So, the U.S. would have to allow registration of a mark if filed properly
under Paris Priority, even if the mark was not able to be legally used in the U.S.
TRIPS permits the cancellation of a mark if it is not used within three years;
however, the agreement recognized valid reasons for non-use as "[c]ircumstances
arising independently of the will of the owner of the trademark which constitute
an obstacle to the use of the trademark, such as import restrictions on or other
5
government requirements for goods or services protected by the trademark."s

Inability to use was at issue for the mark "Havana Club," where a U.S. embargo
52

See Tim Wu, The WTO

the stoner's new best friend., SLATE.COM (Mar. 17, 2005),

http://www.slate.com/articles/news-and-politics/jurisprudence/2005/03/worldweed.html; see
also Drake Baer, 5 countries experimenting with liberal drug laws, BUSINESSINSIDER.COM (Mar.
30, 2016), http://www.businessinsider.com/countries-experimenting-with-liberal-drug-laws-20163.
53 TRIPS: Agreement on Trade-Related Aspects of Intellectual Property Rights art. 15:4, Apr. 15,
1994, Marrakesh Agreement Establishing the World Trade Organization, Annex IC, 1869
U.N.T.S. 299, 33 I.L.M. 1197 (1994) [hereinafter "TRIPS"].
54 Id. at art. 14.
5 See United States Patent and Trademark Offices, Trademark Manual of Examining Procedure §
907 (April 2016), https://tmep.uspto.gov/RDMS/TMEP/current [hereinafter "TMEP"](TMEP's
directions to examiners regarding rejecting marijuana trademarks).
56 See TRIPS: Agreement, supra note 53, art. 15:3.
57 SCM Corp. v. Langis Foods Ltd., 539 F.2d 196 (D.C. Cir. 1976).
5 See TRIPS: Agreement, supra note 53, art. 19:1.
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on Cuba prevented the mark's use in the U.S. 5 9 Because the reason for non-use
was out of the trademark owner's control, the U.S. trademark is not recognized as
abandoned.
In summary, if trying to obtain a trademark in the United States where
marijuana is illegal, a trademark applicant could first apply for the mark in a
TRIPS member country of origin, then subsequently file in the United States
within the Paris Priority period. Consequently, if marijuana is federally legalized
in the United States, the foreign filer could claim priority for the mark. Even if
three years passed and marijuana was still illegal in the United States, the
trademark owner could argue against abandonment because it could not use the
mark in the United States for circumstances it could not control, namely, that it
was illegal under U.S. Federal Law. So, using this strategy could entitle a
trademark owner to priority for its mark.
III. OBSTACLES MARIJUANA IP OWNERS FACE IN ENFORCEMENT
A patent owner has yet to assert a marijuana-related patent in U.S. courts.
However, when that day comes, there are many litigation issues for an illegal
business. Similarly, trademark owners who obtained their trademarks through
laundering or other means may also face an uphill battle when it comes to
litigating. These associated hurdles include problems of equitable defenses such
as unclean hands raised by the other side, problems trying to get an attorney to
work on a case where the business owner is engaging in unlawful activity, and
problems with discovery when one party is avoiding self-incrimination in any
testimony. Further, it may be a burden for a party to find prior art to invalidate a
patent since marijuana has been grown and used in secret for many years.
Additionally, because marijuana is still considered illegal or immoral by many
people, the parties may encounter a biased jury. Finally, a trademark owner risks
cancellation of their trademark if they use the mark for federally illegal goods like
marijuana.
A.

Unclean Hands

A maxim of equity is that a party seeking the aid of a court of equity must
come into court with clean hands. While the Clean Hands Doctrine started as an
equitable doctrine, many jurisdictions also apply it for legal remedies like
damages.6 Courts have applied this doctrine to those engaged in federally illegal

Havana Club Holding, S.A. v. Galleon S.A., 203 F.3d 116 (2nd Cir. 2000).
Byron v. Clay, 867 F.2d 1049, 1052 (7th Cir. 1989) ("But with the merger of law and equity, it
is difficult to see why equitable defenses should be limited to equitable suits anymore; and of
59
60
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businesses when they are seeking equitable relief.6 1 For example, in Fourth
Corner Credit Union v. FederalReserve Bank of Kansas City, a plaintiff involved
in the marijuana industry asked the court to exercise its equitable authority to
issue a mandatory injunction. The case involved a credit union formed to service
marijuana-related businesses, which was denied a "master account" with the
Federal Reserve Bank of Kansas City, a private corporation. The court declined to
force the defendant bank to open the master account because the marijuana
business plaintiff was coming to court with unclean hands. The court declined to

facilitate such criminal activity. The judge concluded that "[a] federal court
cannot look the other way" when a party is violating the law. 62
However, in 2014 a court in California took a different stance in a trademark
case. 63 The case arose after the Military Order of the Purple Heart of the United
States of America (Military Order) sent cease and desist letters to the Purple Heart
Patient Center (PHPC), a medical marijuana seller. In response to the letter,
PHPC filed an action seeking a declaratory judgment from the court that its mark

was not infringing the Military Order's mark. The defendant, the Military Order,
then moved for a judgment on the pleadings due to lack of standing by the
plaintiff,

asserting that the plaintiff could not show the type of damages

cognizable under federal law because the sale of marijuana violates federal law.
In other words, the defendant argued that the plaintiff could not use the Lanham
Act to protect illegal activities. However, the court found that the plaintiff, PHPC,
did have standing because the defendants sent cease and desist letters, raising a

"threat of peril." The court acknowledged the Unclean Hands Doctrine as follows:
While it is a concern that plaintiff could flagrantly violate federal laws
and simultaneously seek the assistance of a federal court of equity to
cancel trademarks, nevertheless, defendants began this controversy by
sending cease-and-desist letters forcing plaintiff to defend itself. If the
trademark owner had sued first for damages, would anyone say that the
defendant would not have had the right to defend itself in court? No, that
would not be the American way. And if that is so, then declaratory relief is
equally available to the accused. Given that defendants seek relief for
alleged trademark infringement arising from registrations which could be

course many are not so limited, and perhaps unclean hands should be one of these.") (citations
omitted); Mona v. Mona Elec. Group, Inc. 176 Md. App. 672, 713 (Sept. 13, 2007)
("Traditionally, the clean hands doctrine only applied in equity. It has been expanded, however, to
cases at law, as well."); Fibreboard Paper Prods. Corp. v. E. Bay Union of Machinists, 227 Cal.
App. 2d 675, 696 (Cal. App. 1st Dist. 1964); Robert N. Leavell, Et. Al., Equitable Remedies,
Restitution, and Damages, 722 (4th ed. 1986).
61 Fourth Corner Credit Union v. FRB of Kan. City, 154 F. Supp. 3d 1185 (D. Colo. 2016).
62 id.
63 Purple Heart Patient Center, Inc. v. Military Order of the Purple Heart of the U.S.A., Inc., 2014
WL 572366 (N.D. Cal. 2014).
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invalid, it would be wrong to deny plaintiff the opportunity to defend
itself.,
The court went on to acknowledge, "[I]t would be unfair to strip plaintiff of this

avenue of defense." And, "[t]aken one step further, if we were to recognize
defendants' theory, then every trademark action would devolve into a side
showing wherein the trademark owner dredges up various other federal laws
supposedly violated by the accused. This cannot be." In summary, the court in
Purple Heart allowed the plaintiff to have its day in federal court after another
party sent cease and desist letters, even though the plaintiff was operating a
business in violation of federal law.
As for patent cases, courts have not yet ruled on the issue of injunctions or
damages for marijuana-related businesses. A court may decide to follow the
reasoning outlined in Four Corner Credit Union and choose not to issue an

injunction to a competitor which would aid the plaintiff s own illegal activity. Or,
it may agree with the reasoning of Purple Heart, and allow the action to proceed.
Indeed, based on these different outcomes, the cleanliness of the party ultimately
demanding damages may determine the application of the doctrine.
B.

Obtaining an Attorney

Attorneys risk violating Rules of Professional Conduct for assisting in
criminal activities.65 Different states have variants of ABA Model Rule of
Professional Conduct 1.2(d)-which broadly permits lawyers to advise clients on
the legal consequences of conduct but prohibits lawyers from assisting clients
with conduct the lawyer knows is criminal.66 One example of a state variant is the
Colorado Rule of Professional Conduct 1.2(d), which states:
A lawyer shall not counsel a client to engage, or assist a client, in conduct
that the lawyer knows is criminal or fraudulent, but a lawyer may discuss
the legal consequences of any proposed course of conduct with a client
and may counsel or assist a client to make a good faith effort to determine
the validity, scope, meaning or application of the law. 67
After Colorado legalized marijuana, lawyers faced a conundrum: if they chose
to represent a client engaging in the marijuana industry, they risked violating the

rules and being disciplined. In response, Colorado's Supreme Court added a

64

Id.

65 Eli Wald, et al., Representing Clients in the MarijuanaIndustry: Navigating State and Federal

Rules, Univ. of Denver Legal Studies Research Paper No. 15-35 (August 5, 2015).
66 ABA Model Rule of Prof'1 Conduct, r. 1.2(d) (Am. Bar Ass'n 2017).
67 Colo. Rules ofProf 1 Conduct, r. 1.2(d) (Colo. Bar Ass'n 2016).
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comment to the Rules to include exceptions that attorneys can assist with
marijuana counseling, but they must advise clients of federal laws and policies.

68

Other states, like Illinois, have also amended their professional rules to
accommodate the laws allowing for medical marijuana usage. In amending the
Illinois Rules of Professional Conduct, the Illinois Supreme Court stated:
The conflict between state and federal law makes it particularly important
to allow a lawyer to provide legal advice and assistance to a client seeking
to engage in conduct permitted by Illinois law. In providing such advice
and assistance, a lawyer shall also advise the client about related federal
law and policy. 69
To date, no attorneys have faced disciplinary action for representing a client in
the marijuana industry in a state which has legalized marijuana. However,
scholars and states remain divided about whether providing a legal service to
marijuana businesses is indeed an ethical violation.70
For example, in Maine, the Professional Ethics Commission pointed out that
the professional rules make no distinction between enforced and unenforced
crimes.7 1 As a result, attorneys in Maine would risk violating ethics rules if they
chose to represent a marijuana business because, even though in Maine it is
unenforced, marijuana is still federally illegal.72
On the other hand, Arizona took a different approach to this problem. An
opinion by the State Bar of Arizona pointed out the problems that could arise if
the industry does not have access to legal counsel in such a highly regulated
industry.7

'

The State Bar of Arizona determined that "[a] lawyer may ethically

counsel or assist a client in legal matters expressly permissible under the Arizona
Medical Marijuana Act, even though such conduct may potentially violate
applicable federal law," so long as "the lawyer advises the client regarding

Colo. Rules of Prof 1 Conduct, r. 1.2, cmt. [14]. (Colo. Bar Ass'n 2016).
In re Amended Rule 705, 2015 Ill. LEXIS 1247 (Oct. 15, 2015).
70 Eric Mitchell Schumann, Comment, Clearing the Smoke: The Ethics of Multistate Legal
68

69

Practicefor RecreationalMarijuanaDispensaries,6 St. Mary's J. Legal Mal. & Ethics 332, 352
(2016).
71 See Advising Clients ConcerningMaine's Medical MarijuanaAct, MAINE PROF'L ETHICS
COMM'N (July 7, 2010),
http://www.maine.gov/tools/whatsnew/index.php?topic=mebar overseers-ethics-opinions&id= 11
0134&v=article.
72 See lan Wagemaker, ProfessionalEthics- The High Risk of Going Green: Problems Facing
TransactionalAttorneys and the Growth of the State-Level Legal MarijuanaIndustries, 37 W.

New Eng. L. Rev. 371, 392 (2015).
73 State Bar of Ariz. Ethics Opinion 11-01, COMM. ON THE RULES OF PROF'L CONDUCT (Feb.

2011), http://www.azbar.org/Ethics/EthicsOpinions/ViewEthicsOpinion?id=710 ("We decline to
interpret and apply ER 1.2(d) in a manner that would prevent a lawyer who concludes that the
client's proposed conduct is in 'clear and unambiguous compliance' with state law from assisting
the client in connection with activities expressly authorized under state law...").
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possible federal law implications of the proposed conduct." 7 4 So Arizona appears
to take the same stance as the state of Colorado, albeit for a different reason.
While Colorado's District Court adopts most of Colorado's RPC as their own,
in 2014 it clarified that the state's exceptions for marijuana were not going to be
allowed at the federal level.7" While the Colorado Supreme Court has adopted the
exception, the District Court has rejected the exception. 76 So, Colorado's state and
federal courts are treating the issue differently. This problem is not unique to
Colorado, as Arizona district courts may choose to take the same stance, resulting
in attorneys still risking violation of ethics rules if practicing in federal courts.
Because of the conflict between state and federal laws regarding lawful
representation under ethics rules, some law firms and attorneys may shy away
from representing those engaged in the marijuana business. This uncertainty for
attorneys is particularly true when medical or recreational marijuana is newly
legal in a state, and the state has yet to amend its ethics rules in response.
While trademark attorneys could still potentially litigate in state courts where
marijuana is legalized, it is unclear whether trademark attorneys still risk violating
ethical or professional rules by representing clients in federal court.
Because federal courts preside over patent litigation, a patent attorney would
be subject to federal rules. Furthermore, many states require an attorney to uphold
both state and federal laws. 77 An attorney federally barred to practice before the
USPTO is additionally bound by the USPTO's Rules of Professional Conduct.
The USPTO's relevant rule is:
A practitioner shall not counsel a client to engage, or assist a client, in
conduct that the practitioner knows is criminal or fraudulent, but a
practitioner may discuss the legal consequences of any proposed course of
conduct with a client and may counsel or assist a client to make a goodfaith effort to determine the validity, scope, meaning or application of the
law.

Thus, a patent attorney would rightfully be hesitant to represent a marijuana
patentee.
This problem is not unique to attorneys, as other professionals face a similar
dilemma. For example, Certified Public Accountants (CPAs) also need to be
cautious when working with marijuana businesses. The American Institute of
Certified Public Accountants (AICPA) released guidelines for CPAs to consider
before providing services to businesses that operate in these industries: "AICPA
74 id.
75
76

See Wald, supra note 65 at 3.
id.

See, e.g., Wash. Admission To Prac. Rules. r. 5(g)(1-2); Ore. Rev. Stat. Ann. § 9.250(2) (West
2017).
78
37 C.F.R. § 11.102(d) (2016).
77
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recommends that all CPAs and CPA firms interested in providing services to
marijuana businesses review the full guidance offered by the U.S. Department of
Justice." 79 As of January 8, 2016, only seven state boards of accountancy had
issued specific guidance for CPAs who may wish to provide services to these
businesses.so Washington and Oregon have permitted CPAs to work with
marijuana businesses, but cautioned them to consider the risks involved."
However, other states are unclear about whether action could be taken against a

CPA if found guilty under a federal act. 82 Nevada decided "[t]he Board's position
does not negate the possibility that disciplinary action may be taken by the Board

should a licensee be found guilty of a federal criminal act."" The AICPA further
cautioned that "[a] state board of accountancy could consider providing services
to marijuana-related businesses as grounds to refuse to grant or renew a license
based on the failure to satisfy the good moral character requirement, or as grounds

for disciplinary action, although none have made such a determination so far." 8 4
C. Fifth Amendment Invoked in Discovery

The U.S. Constitution's Fifth Amendment provides that: "No person... shall
The
be compelled in any criminal case to be a witness against himself."
Supreme Court has extended this right against self-incrimination to the civil

context for when a witness's answers might incriminate him in subsequent
criminal proceedings.86
This issue appeared in a case between a marijuana business owner and the
IRS.

A company operated a marijuana business and wanted to deduct business

expenses, but the IRS would not allow them because of the nature of their
business." The case stated:
79

An Issue Brief on State MarijuanaLaws and the CPA Profession, AM. INST. OF CERTIFIED PUB.

(Jan. 8, 2016),
https://www.aicpa.org/Advocacy/State/DownloadableDocuments/MarijuanaCPAslssueBrief.pdf.
ACCOUNTANTS
s Id.

81 Id.
82 Id.
83 Id.
84 Id.
5 U.S. CONsT.

art. V.
See McCarthy v. Arndstein, 266 U.S. 34 (1924) (the Fifth Amendment "applies alike to civil
and criminal proceedings, wherever the answer might tend to subject to criminal responsibility
him who gives it."); see also Wehling v. Columbia Broadcasting Sys., 608 F.2d 1084, 1086 (5th
Cir. 1979) ("Even if the rules did not contain specific language exempting privileged information,
it is clear that the Fifth Amendment would serve as a shield to any party who feared that
complying with discovery would expose him to a risk of self-incrimination. The fact that the
privilege is raised in a civil proceeding rather than a criminal prosecution does not deprive a party
of its protection.") (citing Lefkowitz v. Cunningham, 431 U.S. 801, 805 (1977))
87 See Feinberg v. Comm'r of Internal Revenue, 808 F. 3d 813 (10th Cir. 2015).
86

" Id. at 814.
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"As the litigation progressed, though, the IRS issued discovery
requests asking the petitioners about the nature of their business - no
doubt seeking proof that they are indeed trafficking in marijuana, just as
the agency alleged. The petitioners resisted these requests, asserting that
their Fifth Amendment privilege against self-incrimination relieved them

of the duty to respond." 8 9
The IRS then filed a motion to compel discovery, which the Tax Court

granted. 90 The Tenth Circuit denied the Colorado marijuana business' plea to
overturn the U.S. Tax Court's decision that it must comply with the IRS's
requests for information about the nature of its business because the lower court
case was still ongoing. 9 1 The business owner needed to wait for a final judgment
in order to appeal. 92 Regardless, the business owners still had the option to obtain

an appealable final judgment either by choosing to defy the tax court's order or
comply under protest, after which the circuit court could order a new trial without
the materials in question. 93 Importantly, the 10' Circuit did not say that the option
of invoking the Fifth Amendment was off the table or lacked merit, but that it
could not rule on the issue until a final judgment had occurred. 94
A business may choose to refuse to answer discovery questions that would
connect it to selling marijuana or otherwise violating the CSA. In patent law,
refusing to answer could cut either way for a patent holder. If the patent holder
invoked the Fifth Amendment, it could help the patent holder because they would
not be forced to disclose prior art in discovery. On the other hand, invoking the
Fifth Amendment could mean that a defendant would not have to testify about the
production of the product, claiming a risk of self-incrimination. It has yet to be
addressed by the courts as to whether invoking the Fifth Amendment in patent
litigation will bar discovery.
In trademark litigation, a defendant may counter argue that the USPTO should
cancel the trademark because it is being used for marijuana. 95
the plaintiff may try to invoke the Fifth Amendment.

In that situation,

In civil proceedings, unlike criminal proceedings, adverse inferences can be
drawn from a party's invocation of this Fifth Amendment right. 96 So, if parties in

89 Id.
90

Id. at 815.

91 Id.
92 Id.

93 Id.
94 Id.

95 See 15 U.S.C. § 1051.
96 See Baxter v. Palmigiano, 425 U.S. 308, 318 (1976); see also SEC v. Colello, 139 F.3d 674, 677

(9th Cir. 1998); see also United States v. Solano-Godines, 120 F.3d 957, 962 (9th Cir.1997) ("In
civil proceedings, however, the Fifth Amendment does not forbid fact finders from drawing
adverse inferences against a party who refuses to testify.").
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either patent or trademark litigation were to invoke their Fifth Amendment right,
the jury could draw adverse inferences that may substantially affect the case.

D. Finding PriorArt
Another potential issue in marijuana litigation is finding prior art because
people have been growing and using marijuana in secret for so many years.
When software patents became patentable, a similar issue existed with finding
software prior art because many times the prior art was not published, rather just
used in private computers. In response to this issue, Microsoft, IBM, and Apple
sponsored the Software Patent Institute. 97 Projects like this made more software
prior art available to patent examiners in an effort to protect the quality and
legitimacy of issued software patents. 98 Essentially, this led to a database that
ensured that patents were not issued for technology already in use. The mission of
the program is:
The Software Patent Institute (SPI) is a nonprofit corporation formed to
provide prior art related to software technology with the intention of
improving the patent process. We strive to aggregate hard-to-access
software data which is not readily available online or in electronic form
elsewhere. Our source documents include computer manuals, older
textbooks, journal articles, conference proceedings, computer science
theses, and other such materials which may contain valuable prior art. 99
For marijuana strains, a similar database is being developed with the Open
Cannabis Project."oo The mission of the Open Cannabis Project is very clearly to
prevent the patenting of marijuana strains that are already in use: "The Open
Cannabis Project is building an archival record of all existing cannabis strains, in
order to ensure that they remain forever in the public domain, available to all, and
will not be restricted by commercialization or patenting."10 1
With cannabis strains, there is often no proof that a strain is not new. And,
once the patent issues, proving that it was already in use becomes very difficult.
So, the Open Cannabis Project aims to disclose these strains to ensure that they
are non-novel and thus unpatentable.
While the marijuana industry is booming and companies in the industry are

more sophisticated than ever before, "[t]his industry came up in stealth, born in

About SPI, SOFTWARE PATENT INSTITUTE (Oct. 23, 2017), http://spi.org/about-spi.jsp.
98 Daniel W. McDonald, et al., Software PatentLitigation, (Apr. 2006),
http://euro.ecom.cmu.edu/program/law/08-732/Patents/SoftwarePatentLitigation.pdf.
99 See About SPI, supra note 97.
100 THE OPEN CANNABIS PROJECT, http://opencannabisproject.org (last visited Oct. 23, 2017).
97

101 Id.
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basements and crawl spaces. . . [t]his started as a hippy industry." 10 2 Prior art is
much more difficult to come by when the industry previously lacked any database
of what was already in the public domain.

However, this problem will likely

begin to diminish, as today's top breeders are geneticists and other researchers
10
funded by pharmaceutical companies.o

They now have access to sophisticated

technology, like gas chromatography, and are more organized than ever before.

104

"We are certainly getting away from the free-love mentality. Patents is a pure

money play."10 5
E. Jury Bias
Because marijuana is something that many in our nation do not support or
strongly condemn, potential jury bias is another issue that could potentially affect
a trial. Even in states where the people voted marijuana to be legal, these may
have been close elections. For instance, in the May 2016 vote in Maine, just a few
thousand votes separated the issue. 106 Jury bias may be a non-issue when both
parties are involved in the marijuana industry, like when a marijuana patent owner
sues another marijuana business that is making, using, or selling the patented
strain. However, jury bias could present an issue if the marijuana patent owner is
a non-practicing entity, and may not be engaged in the marijuana business.

A

biased jury who may not approve of the marijuana industry in the area may
support shutting down a marijuana business or may grant a large judgment to
have that effect.
In trademark litigation at the state level, a marijuana trademark owner may
face a near impossible feat if the jurors selected are not in favor of legalized
marijuana. It is important for a fair trial that courts dismiss people with potential
biases about marijuana from jury selection during voir dire.
F. Risk of Cancellation of the Trademark
While there are strategies, such as trademark laundering, for obtaining rights,
courts have the authority under 15 U.S.C. § 1119 to order the cancelation of

102 See Jason Blevins, Pot growers cultivating in the shadows seek U.S. patentprotection, THE

DENVER POST (Apr. 26, 2016), http://www.denverpost.com/2014/12/19/pot-growers-cultivatingin-the-shadows-seek-u-s -patent-protection/.
103 Id.
1
Id.
105

Id.

See Christopher Ingraham, Marijuanawins big on election night, THE WASHINGTON POST
(Nov. 8, 2016), https://www.washingtonpost.com/news/wonk/wp/2016/11/08/medical-marijuanasails-to-victory-in-florida/'Autm term=.6fbec 17de72c
106
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trademark registrations. 10 7 In litigation, a defendant in a trademark infringement
suit may even assert a counterclaim requesting the cancellation of the mark due to

lack of use. "[A] registration may be vulnerable to cancellation if the goods and
services for which the registration has been issued, are proven to be unlawful." 0 8
In Trans-High Corporation v.

Reimers, the district court considered

the

defendant's counterclaim that the plaintiff was selling unlawful goods not listed in
the

trademark registrations,

specifically

drug paraphernalia

and controlled

substances (marijuana). The court ultimately rejected this argument because the
plaintiff was merely advertising these items in its magazine, rather than directly
selling them, and the CSA excludes advertising.
Yet, Trans-High Corporationv. Reimers is distinguishable from a scenario in
which a marijuana-related business engages in trademark laundering and is selling
drug paraphernalia or controlled substances. In such a case, the party would be in
violation of the CSA, and a court could use its authority under 15 U.S.C. § 1119
to cancel the trademark.
IV.

TRENDS FOR HOW COURTS TREAT MARIJUANA CASES IN OTHER
AREAS OF LAW

Currently, federal trademarks are not issuing for marijuana, and there are no
cases on point for how a court will treat a patent litigation case involving
marijuana. When a court does rule on the issue, it will likely review cases from
other areas of law in forming its opinion. The following areas of law involve civil
cases and marijuana: bankruptcy, banking, contract law, employment law, and tax
law.
A. Bankruptcy
While marijuana businesses are subject to many of the burdens of federal law,
they are not entitled to many of the benefits that federal law provides. 109 The
inability to take advantage of federal benefits puts marijuana business owners at a
disadvantage compared with business owners that operate in a federally legal
arena. One federal benefit not available for marijuana businesses is bankruptcy
protection.

15 U.S.C. § 1119 (2012).
'0s See Trans-High Corp. v. Reimers, No. 2:14-CV-00279-LRS, 2015 WL 144417, at *2 (E.D.
Wash. Jan. 12, 2015).
107

See Sam Kamin & Viva Moffat, Trademark Laundering, Useless Patents, and Other IP
Challengesfor the MarijuanaIndustry, 73 Wash. & Lee L. Rev. 217, 219-20 (2016) (discussing
109

how marijuana businesses are denied the regulatory benefits of federal IP law while suffering its
burdens).
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As noted earlier, the Doctrine of Clean Hands prevents equitable relief when
businesses operate illegal enterprises. For instance, in In re Rent-Rite Super Kegs
W. Ltd., the Court found that the debtor was engaged in an ongoing criminal
violation of the CSA by knowingly leasing part of a warehouse to tenants who
used the space to grow marijuana.110 The court held that there was cause to
dismiss the bankruptcy case because the debtor came to court with unclean hands.
Similarly, in In re Arenas, a marijuana business that was licensed to grow and
dispense medical marijuana in Colorado tried to declare bankruptcy, and the court
would not allow it because the activities the business engaged in, although legal
under Colorado law, were in violation of the CSA. 1 11 The

1 0 th

Circuit Bankruptcy

Appellate Panel in In re Arenas upheld the lower court's denial because the
business owners were unable to propose a good faith Chapter 13 plan. 112

The

court reasoned that the business owners could not afford their reported monthly
expenses without using the proceeds of the marijuana growing operation, and any
plan would require the trustee to take possession, sell, and distribute marijuana in
violation of federal law. The judge noted the following in his conclusion:
In this case, the debtors are unfortunately caught between pursuing a
business that the people of Colorado have declared to be legal, but which
the laws of the United States- laws that every United States Judge swears
to uphold- proscribe and subject to criminal sanction. Because of that
neither a Chapter 7 nor 13 trustee can administer the most valuable assets
in this estate. Without those assets or the marijuana bases income stream,
the debtors cannot fund a plan without breaking the law, and are therefore

ineligible for relief under Chapter 13.113
Further, in In re Medpoint Management, LLC., the Bankruptcy Court for the
District of Arizona held that creditors of a marijuana business knew the business
was illegal and did not allow them to utilize the bankruptcy court. 114 The court
said "[p]etitioning Creditors' hands are unclean and they cannot now seek relief

from this Court."
Like injunctions sought in patent litigation, bankruptcy proceedings are a form
of equitable relief under the jurisdiction of federal courts. It is possible that
federal courts will analogize these two types of equitable proceedings; however,
the courts may rule differently if a non-practicing entity asks for an injunction to
stop a business. In the case of a non-practicing entity seeking an order against a
marijuana business, a judge would actually prevent illegal activity by granting an
injunction.
110 In re Rent-Rite Super Kegs W. Ltd., 484 B.R. 799, 809 (Bankr. D. Colo. 2012).
" In re Arenas, 535 B.R. 845, 849-50 (B.A.P. 10th Cir. 2015).
112 Id. at 852.
113 Id. at 854.
114 In re Medpoint Management, LLC., 528 B.R. 178-79 (Bankr. D. Ariz. 2015).
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B. Banking
Often it is challenging for marijuana businesses to find a bank due to the
expensive compliance hurdles and uncertain legal consequences banks face. 115
Banks may face civil or criminal liability if they knowingly accept proceeds from
marijuana transactions, so many banks simply refuse service to marijuana
businesses.11 6 Further, if banks knowingly violate federal law, they cannot hold
FDIC insurance. In October of 2015, only about 220 banks and credit unions
accepted cash connected to marijuana businesses.1 17 The federal barriers for bank
compliance include the CSA, USA Patriot Act, Bank Secrecy Act, and the
Racketeer Influenced and Corrupt Organizations Act.
It is a criminal offense to engage in monetary transactions with the proceeds
of specified unlawful activity, including proceeds from marijuana-related
activities in violation of the CSA.
Under the Bank Secrecy Act, banks are required to assist government agencies
in detecting and preventing money laundering. The BSA requires the financial
institutions to monitor and report cash transactions exceeding $10,000 and to file
suspicious activity reports that may signify criminal activities. In February of
2014, the Financial Crimes Enforcement Network (FinCEN) issued guidance for
banks providing services for marijuana-related businesses, which included
extensive requirements for financial institutions to meet. Also, if a bank offers
financial services to a marijuana-related business, the bank must file suspicious
activity reports.
Another financial hurdle that marijuana businesses face is that the official
rules of payment processing companies, such as Visa, MasterCard, and American
Express, which prohibit the use of their debit and credit cards for marijuana
purchases." For this reason, many marijuana businesses are only allowed to
accept cash which contributes to the more significant problem of a high volume of
hard cash flow, but nowhere to put it.

115

Jennifer Kaplan, Finding a Placefor Cannabis Cash, BLOOMBERG BUSINESSWEEK (Oct. 15,

2015, 2:33 PM), https://www.bloomberg.com/news/articles/2015-10-15/finding-a-place-forcannabis-cash.
116 Antony Ireland, The Contradictionof Marijuana,RISK & INSURANCE (Oct. 1, 2015),
http://riskandinsurance.com/the-cannabis-contradiction/.
117 See Kaplan, supra note
115.
118 Moises Gali-Velasquez, Changes Needed to Protect Banking and FinancialServices When
Dealing with the MarijuanaIndustry, LEXIS PRACTICE ADVISOR J. (Aug. 3, 2016),
https://www.lexisnexis.com/lexis-practice-advisor/the-journal/b/lpa/archive/2016/08/03/changesneeded-to-protect-banking-and-financial-services-when-dealing-with-the-marijuana-industry.aspx.
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Thus, in effect, businesses involved in the marijuana industry are prevented
equal access to financial institutions. The federal government forces the banks to
treat their business differently because they are breaking federal laws.
C. Insurance/ContractLaw
Insurance and contract law is purely state law, so it varies by district.

The

trend right now is hard to predict because of this variance, but federal courts have
addressed the role public policy plays when asked to rule on an issue that violates
federal law.
In 2012, the District Court of Colorado held in Haeberle v. Lowden that a
contract for the sale of medical marijuana between a cultivator and a medical
marijuana business engaged in retail sales was void and unenforceable for public
policy reasons. 119

The court reasoned, "contracts in contravention of public

policy are void and unenforceable," and if a "disputed contract violates federal
law, it would be against public policy and would be void and unenforceable." 12 0
The court emphasized that marijuana possession and use remains illegal under
federal law, and federal law regarding marijuana preempts state law. In effect, the
court found that contracts for the sale of marijuana are void as they are against

public policy.
In 2012, the Superior Court of Arizona held in Hammer v. Today's Health
Care II that a contract for a loan agreement for financing a retail medical
marijuana sales and grow center was void and unenforceable.

12 1

In Hammer, the

two plaintiffs loaned $250,000 each to a dispensary, but the dispensary defaulted

on the loan. The court gave the plaintiffs no remedy, stating, "[t]he explicitly
stated purpose of these loan agreements was to finance the sale and distribution of

marijuana. This was in clear violation of the laws of the United States." The court
went on to say that equitable relief, like unjust enrichment, would not be available
since the contract was void as against public policy.

One who enters into an

illegal contract "is not only denied enforcement of his bargain, he is also denied
any restitution for any benefits he had conferred under the contract." 12 2 Thus, the
court in this case ruled out both legal damages and equitable damages.
In 2016, however, the Northern District of California upheld a contract
relating to the medical marijuana industry where the contract included evidence of

119 Order Denying Plaintiff's Motion to Strike at 8, Haeberle v. Lowden, (Colo. D. Ct. Aug. 8,
2012) (No. 201 1CV709).

120

id.

Judgment of Dismissal, Hammer v. Today's Health Care II, CV2011-051310, at *2, *4 (Ariz.
Sup. Ct. Apr. 12, 2012).
121

122 Id. at *4.

2017

AM. U. INTELL. PROP. BRIEF

ties to medical marijuana.

123

50

The plaintiff sued for breach of contract after the

defendant defaulted on payment, and the defendant contended that the agreement
was "void ab initio because it related to medical marijuana, which is still a

prohibited substance under the federal Controlled Substances Act."

1 24

The

defendant claimed that it could only make payments promised with revenue from
operating the marijuana businesses and that the plaintiff was aware of that.

125

Here, the court found that it could grant relief that would not require the
defendant to break federal law, since the defendant had not proven that using
funds from its medical marijuana business was its only means of repayment.

126

Further, the court emphasized that even though the nature of the business may
indirectly involve medical marijuana, if the court enforced the agreement it would
deter other potentially illicit conduct.

127

Namely, the defendant, due to its illegal

dealings, could avoid paying for services rendered pursuant to a contract. 128 In
summary, the court allowed recovery for a contract involving a marijuana
business because a remedy existed that would not require the court to order a
violation of federal law, and it was in the interest of public policy to deter further
illicit conduct by the defendant. 129 Courts are still divided about whether to
uphold marijuana-related contracts. Further, as will be discussed below, insurance
contracts are also a divided issue.

In 2012, the District Court of Hawai'i held in Tracy v. USAA Casualty
Insurance Company that enforcing an insurance policy covering items in violation
of federal law is contrary to public policy."1o In Tracy, the plaintiff was growing
twelve marijuana plants in their house as was consistent with Hawaiian law,
which permitted individuals to grow marijuana for medical purposes. The plants

were stolen and the plaintiff tried to recover through a homeowner's insurance
policy with USAA.

The court refused to enforce the insurance provision that

would allow recovery of the plants "because Plaintiff's possession and cultivation
of marijuana, even for State-authorized medical use, clearly violates federal law."
In 2016, the District Court of Colorado held differently than in Haeberle v.

Lowden in 2012 and expressly declined to follow the Hawaiian court's reasoning
in Tracy."1 ' In Green Earth Wellness v. Atain Specialty Insurance, the court held
123 Order Denying Motion for Summary Judgment, Mann v. Gullickson,
No. 15-cv-03630-MEJ,
2016 WL 6473215 at *1 (N.D. Cal. Nov. 2, 2016).
124 Id. at *2.
125 Id.
126 Id. at *7.
127 Id.
128 Id.
129 Id. at *8.
130 Tracy v. USAA Cas. Ins. Co., No. 11-00487LEK-KSC, 2012 WL 928186 at *1, *13
(D. Haw. Mar. 16, 2012)(order granting motion of summary judgement).
131 Green Earth Wellness Ctr., LLC v. Atain Specialty Ins. Co., 163 F. Supp. 3d 821 (D. Colo.
2016).
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that it was not against public policy to enforce an insurance contract for a claim
for marijuana losses. After a nearby wildfire, smoke and ash overwhelmed the

company's ventilation system, which in turn damaged the marijuana plants.
Additionally, plaintiff made a claim for theft of marijuana plants. The court
distinguished this case from others since both parties were aware that they were

insuring marijuana. The court held that the insurance company, "having entered
into the Policy on its own will, knowingly and intelligently, is obligated to

comply with its terms or pay damages for having breached it." It also noted the
"several additional years evidencing a continued erosion of any clear and
consistent federal public policy in this area," and declined to declare the policy
void on public policy grounds and allowed the case to go forward to trial.
Thus, in 2016, Tracy and Green Earth provided two contrary opinions on
whether it was against public policy to require insurance companies to allow
recovery for marijuana plants. In four years, Colorado changed its tune in
response to apparent acquiescence by federal authorities in the prosecution of
marijuana crimes in recent years. When both parties are aware of the illegal
activity, at least in Colorado, the courts are willing to hear cases in which a party
seeks to enforce a contract signed with such knowledge. Similarly, as evidenced
in Mann v. Gullickson, California district courts are enforcing contracts when a
party enters into the contract with knowledge of the illegal activities. Thus, the
trend appears to be that if a party has knowledge of illegal activities and still
enters into an agreement, they cannot later renege on their agreement due to the

illegal activity.
Notably, in all these district court cases, the parties were in federal court due
to diversity jurisdiction. In cases dealing with a federal patent or trademark rights,
the courts would have federal question jurisdiction. The fact that states have
legalized marijuana may be less relevant because federal law would control. On
the other hand, if enforcing a licensing agreement where the parties agreed to a

choice of law, then the state's law may become relevant.
G. Employment Law
The laws governing whether an employer can fire an employee for using
medical marijuana vary by state. 132 The conflict between federal and state laws is
leading to confusion for employers because in many states it remains unclear
which law to enforce with their employees and whether to permit marijuana use.
In California, the Supreme Court held in Ross v. Ragingwire Telecommunications,
Inc. that under state law, an employer could fire an employee who used medical
Ari Lieberman & Aaron Solomon, A cruel choice: patientsforced to decide between medical
marijuanaand employment, 26 HOFSTRA LAB. & EMP. L. J., 619 (2009).
132
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marijuana under the Compassionate Use Act, even it was if used at home and did
not affect work performance.

However, in Rhode Island and Connecticut, the

medical marijuana laws provide that an employer cannot discriminate against
those who use medical marijuana.1 34 Arguably, in California or other states that
follow suit, the state is allowing the employer to determine the best medical
decision for its employee, something normally left to the patient and its doctor.

135

Uncertainty exists as to how the other states that allow medical marijuana will
handle the issue.

Montana's Medical Marijuana Act states that nothing in the act should be
construed to require "an employer to accommodate the use of marijuana by a
registered cardholder," to "prohibit an employer from including in any contract a

provision prohibiting the use of marijuana for a debilitating medical condition," or
to permit a cause of action against an employer for wrongful discharge... or
discrimination."136 So, in Montana, an employer could fire an employee for using
marijuana and not face a lawsuit.
Similarly, in Oregon, the Supreme Court held in Emerald Steele v. Bureau of
Labor and Industries that a state law that authorizes marijuana use, for any
reason, is an obstacle to Congress achieving the goals of the CSA.1 37 So, the

employer did not have to accommodate the employee's medical marijuana usage.
The trend for medical marijuana users seeking relief after their employer fired
them for positive drug tests is that courts are ruling against the marijuana user. 138
The courts are ruling in favor of the employers for two main reasons: (1) Federal
law preempted any state law purporting to legalize marijuana use, or (2) the state
statutes were silent on employment and did not remove an employer's power to
fire for drug use. 139 In states where courts rule a certain way due to preemption,
they may choose to rule the same way in IP litigation. While employment law is
under state jurisdiction, it is relevant to see how the courts treat another issue
where the state and federal marijuana laws are conflicting. Courts' decisions
regarding employment law could inform how courts handle state trademarks.
H. Tax Law

Ross v. Ragingwire Telecommunications, Inc., 174 P.3d 200 (Cal. 2008).
R.I. Gen. Laws § 21-28.6-4(d) (West 2014); Conn. Gen. Stat. Ann. § 21a-408p(b)(3) (West
2015).
135 See Lieberman, supra note 132.
136 Mont. Code Ann. § 50-46-320.
137 Emerald Steele v. Bureau of Labor and Industries, 230 P.3d 518
(Or. 2010).
138 Kathleen Harvey, Protecting medical marijuana users in the workplace, 66 Case West. Res. L.
Rev. 209, 218 (2015).
133

134

139 Id.
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The U.S. Tax code requires that businesses who are "trafficking in controlled
substances" according to the CSA may not utilize many tax deductions and credits
available

to

other businesses,

employee-related expenses.

14 0

like

deducting

rent,

advertising

costs,

and

So, sellers of Schedule I controlled substances are

required to pay taxes on their gross revenue instead of their net income. 14 1 This
inability to make tax deductions puts marijuana businesses at a steep disadvantage
in comparison to federally legal businesses.
In 2007, the U.S. Tax Court in Californians Helping to Alleviate Medical
Problems, Inc. v. C.LR. held that this rule against deduction of business expenses
related to drug trafficking does not preclude deduction of expenses for a nondrug-related business of the taxpayer. 14 2 Businesses had been relying on this
ruling for years to deduct some expenses for the businesses, just not for the
marijuana itself.
However, in 2012, the Tax Court in Olive v. C.LR held that marijuana

business expenses are not deductible. The court said "[t]he dispensing of medical
marijuana, while legal in California, among other states, is illegal under federal
law. Congress in section 280E has set an illegality under Federal law as one
trigger to preclude a taxpayer from deducting expenses incurred in a medical
marijuana dispensary business. This is true even if the business is legal under

State law."
While marijuana businesses are legal in some states, the IRS still considers
these businesses to be in violation of the CSA and prevents them from taking
deductions that legitimate businesses may utilize.
CONCLUSION
While many states are legalizing marijuana, the drug remains illegal by
federal standards under the Controlled Substances Act. Even though federal law
does not recognize marijuana as having any legitimate medical use, the United

States Patent and Trademark Office's patent division has begun issuing utility
patents for marijuana. However, the trademark division of the USPTO is still
rejecting trademarks because of a lack of legal use in commerce. While state
trademarks are available, they are less valuable for a business than a federal
trademark because they are geographically limited. Some parties have opted to
trademark launder to try to obtain trademark rights for marijuana, but courts will
likely cancel these marks in litigation.
26 U.S. Code § 280E (2012); see also Tom Huddleston, Jr., The marijuanaindustry's battle
againstthe IRS, FORTUNE (April 5, 2015), http://fortune.com/2015/04/15/marijuana-industry-taxproblem/.
141 26 U.S. Code § 280E (2012) (provides that sellers of Schedule I controlled substances must
pay taxes on their gross revenue instead of their net income).
142 Californians Helping to Alleviate Med. Problems, Inc. v. C.I.R., 128 T.C. 173
(T.C. 2007).
140
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Litigating marijuana IP will inevitably invoke a variety of issues for the IP
owner. For instance, a court may dismiss a case due to the Clean Hands Doctrine
since marijuana is still against federal law. Also, parties in the marijuana industry
may have difficulty obtaining an attorney, particularly in federal court because the

attorney's Rules of Professional Conduct do not allow attorneys to assist in
unlawful activity. Another potential problem could arise with discovery if one
party attempts to avoid self-incrimination. Further, it may be a serious burden for
a party to find prior art to invalidate a patent when marijuana has been a secret
business for so many years. Because marijuana is still considered illegal or
immoral by many people, the parties may encounter a biased jury. Finally, a
trademark owner who is using the mark on federally illegal goods risks the court
cancelling the mark.
In deciding where to litigate, an attorney might look to other areas of law
where civil courts have ruled on marijuana business rights. For instance, parties in
civil

cases

have

brought claims

for bankruptcy, banking, contract law,
employment law, and tax law. Some courts ruling on bankruptcy, an equitable
issue, have not permitted marijuana businesses to utilize the bankruptcy courts.
Courts have reasoned that public policy prevents them from allowing a business
engaged in federally illegal activity to benefit from federal equitable options. Like
bankruptcy, injunctions sought by IP owners are an equitable remedy.

A court

may decline to grant an injunction because a party is engaged in illegal activity.
With banking regulations, the federal government makes it more difficult for
banks to work with marijuana businesses.

The federal government treats

businesses that are involved in the marijuana industry differently than other
businesses regarding access to financial institutions.
In contract law, the trend appears to be that if a party has knowledge of illegal
activities and still enters into an agreement, they cannot later renege on their
agreement due to the illegal activity. But, the courts are divided on this issue, with
some courts still declining to offer any remedy for businesses involved with
marijuana. Notably, for the contract law cases discussed in this note, the parties
were in federal court due to diversity jurisdiction. In cases dealing with a federal
patent or trademark, the courts would have federal question jurisdiction. The fact
that states have legalized marijuana may be less relevant because federal law
would control.
With employment law, the trend is that courts are not siding with marijuana
users because of federal preemption of state marijuana laws, and federal law still
prohibits marijuana usage.

Finally, tax courts have not allowed marijuana

businesses the same benefits as other businesses. The IRS is still considering
marijuana businesses to be in violation of the CSA and is not allowing them to
take advantage of deductions that legitimate businesses may utilize.
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Marijuana IP owners seeking a remedy in federal court may face difficulties
due to the connection with federally illegal activity. A business owner would
benefit from litigating in state versus federal court when possible. If federal court
is necessary, like in patent litigation cases, it would be wise to choose a venue
where the courts have allowed marijuana business owners to recover damages in
other areas of law.
If parties license marijuana IP in a contract, they could include a choice of law
by consenting to the exclusive jurisdiction of a particular court. A marijuana
business may opt for a venue where the courts allow marijuana businesses to
litigate legal issues. Additionally, patent owners may choose to include an
arbitration clause in a license agreement as a strategy to avoid federal court.
Arbitration

is

common

with

license

agreements,

especially

international

agreements, and courts are not required to approve arbitrators. Indeed, courts are
rarely involved unless a party appeals or tries to enforce an arbitration award.
How courts will treat marijuana patents in litigation remains unseen. As for
marijuana trademarks, state protection is the only option for many businesses.
Marijuana IP litigation is still the Wild West for courts, and only time will tell
how courts will ultimately treat this area of law.
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